Literature DB >> 36268326

Operative versus non-operative management for perforated peptic ulcer disease.

Sapna Gupta1, Awad Ali Alawad2, Kimberly Dacosta3, Adel Mahmoud4, Taghreed Mohammed5.   

Abstract

Perforated peptic ulcer (PPU) treatment guidelines are still up for discussion. Due to the morbidity and mortality linked to each, the use of both operative and non-operative management, including conservative and endoscopic treatment, is still debatable. A standardized protocol has been used to write a best evidence topic. The discussion focused on whether operative management for PPU is preferable to non-operational management or vice versa. MEDLINE, the Cochrane Library, Scopus, and the Web of Science were the databases used to conduct an electronic search of the pertinent literature. We found 56 articles, out of these only 5 studies were found to be appropriate to answer the question. The outcome assessed was failure of management. The best evidence showed that both operative and non-operative management can be used with similar outcomes depending on the patient selection for each category.
© 2022 The Authors.

Entities:  

Keywords:  Management; Operative versus non-operative; Perforated peptic ulcer

Year:  2022        PMID: 36268326      PMCID: PMC9577597          DOI: 10.1016/j.amsu.2022.104643

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


Introduction

A best evidence topic (BET) provides evidence-based solutions to frequent clinical issues through a structured technique of literature review. The International Journal of Surgery's design was used to build this BET [1]. This framework was used because a previous literature assessment indicated that the quality of the information available was insufficient to carry out a useful systematic review or meta-analysis.

Clinical scenario

A 65-year-old male patient with history of arthritis and ischemic heart disease presented to accident and emergency department with sudden onset upper abdominal pain. Investigations confirmed localised perforated duodenal ulcer. Surgical team looking after the patient is debating whether to manage this operatively or non-operatively based on best evidence available.

Three-part question

Does [operative management ] preferred over [non-operative management] in patients with [perforated peptic ulcer]?

Search strategy

Embase 2002 to October 2021 using the OVID interface: [perforated peptic ulcer] AND [management] AND [operative] AND [non-operative] OR [conservative] Medline using the PubMed interface: [perforated peptic ulcer] AND [management] AND [operative] AND [non-operative]. The results were limited to English articles and human studies.

Search outcome

There were 56 articles that might be relevant. After eliminating duplicate references and unrelated literature, twelve candidate articles remained. After carefully reading the complete contents of these articles, five papers were selected to give the most convincing supporting information to address the subject.

Result

See the table.

Discussion

Perforated peptic ulcer (PPU) is a common surgical emergency. Over the last 50 years, although there has been a dramatic fall in the prevalence of peptic ulcer disease (PUD) due to use of treatment for elimination of Helicobater pylori, the number of patients needing surgery has remained mostly unchanged [2,3]. The viability of nonoperative care for PPU was not demonstrated until the results of the first randomised controlled trial were published in 1989. According to Crofts et al. [4], nonoperative therapy using comparable methods can effectively treat approximately 72% of cases with comparable morbidity and mortality as compared to the immediate surgical group. Perforated peptic ulcer is currently treated medically and surgically, both of which have benefits and drawbacks of their own. Determining the optimal course of treatment for the patient can be challenging for the clinician as a result. Medical management for PPU include intravenous antibiotics, nil by mouth and a nasogastric tube, anti-secretory and anti-acid medication (PPIs) and a water-soluble contrast imaging study to confirm a sealed leak [5]. Many studies in the past have demonstrated that PPU can seal spontaneously with successful non-operative strategy [6,7]. Cao et al. [7] have demonstrated that degree of secondary peritonitis should be the primary consideration when choosing the treatment strategy because it poses a greater risk to the patients' lives than the peptic ulcer itself. In patients with few or isolated symptoms and is in good clinical health non-operative management must be considered. However, consideration should be given to the reported mortality increase that occurs with every hour of delay to surgery [[8], [9], [10], [11]]. Endoscopic treatment e.g. clips or stents presents an alternative between non-operative and operative treatment. Although not used routinely, some studies have demonstrated lower mortality rate in patients undergoing endoscopic management and were discharged without additional surgical procedures [12,13]. Options for surgical treatment for PPU include open surgery or laparoscopic surgery. Laparoscopy is not yet supported by any evidence that it is superior to open surgery or that it is hazardous to individuals who have sepsis or widespread peritonitis [5], hence both surgically approaches are widely used based on surgeon's experience. Studies included in our review are to help identifying best evidence practice for patients with PPU. Karabulut et al. [14] in their retrospective study with 41 patients demonstrated that the length of stay was similar in patients treated with conservative or surgical management. Conservative approach was suggested for patient with normal vital parameters and no signs of generalised peritonitis, while surgical treatment was for patients demonstrating sins of sepsis and peritonitis. A prospective randomised control trial of 100 patients by Negm et al. [15] comparing endoscopic treatment with surgical treatment concluded that in high-risk surgical patients, combined endoscopic and interventional radiological drainage can effectively treat acute perforated peptic ulcer without the requirement for general anaesthesia, with minimal to no additional morbidity or mortality. Another study by Cao et al. [7] demonstrated that nonoperative management was effective and safe in selected patients without peritonitis with similar length of hospital stay as patients with operative management. A prospective randomised study of 43 patients by Vazquez et al. [16] demonstrated that, a safe alternative to conventional surgical closure for perforated duodenal ulcers is stent treatment in conjunction with laparoscopic lavage and drainage. Stent treatment is also a good alternative in cases of suture-line leakage. Study by Rahuman-et al [17] with 491 patients case selection is important for various treatment options. Low risk, healthy patients can be treated with conservative management. For high risk patients elderly patients with multiple co-morbidities percutaneous abdominal drainage is suitable whereas medium risk patients with peritonitis should be treated with surgery. In conclusion, the evidence of an optimal strategy for patients with PPU is currently based on a few studies most of which are retrospective single-institution studies. The use of non-operative therapy in patients who are healthy with minimal disease as well as in frail patients is a topic of current controversy. Large-scale research may yield greater information on the patient selection for conservative treatment, which is currently understudied.

Clinical bottom line

According to one prospective randomised controlled trial, one retrospective randomised control trail and 3 retrospective cohort studies there is no statistically significant difference between operative and non-operative management for perforated peptic ulcer.

Limitation of this review

Small sample size in some studies Four out of fiver studies were single centre Most studies were retrospective rather than prospective

Ethical approval

Not applicable.

Sources of funding

No sources of funding

Author contribution

Sapna Gupta: conducted the literature search and wrote the paper. Awad Alawad: assisted in the literature search and writing of paper. Kimberly DaCosta: assisted in writing of paper. Adel Mahmoud: assisted in writing of paper. Taghreed Mohammed: assisted in writing of paper.

Trial registry number

1.Name of the registry: 2.Unique Identifying number or registration ID: 3.Hyperlink to your specific registration (must be publicly accessible and will be checked):

Guarantor

Sapna Gupta.

Consent

Not applicable.

Provenance and peer review

Not commissioned, externally peer reviewed.

Declaration of competing interest

No conflicts of interest.
Author, date of publication, journal and countryStudy typePatient groupOutcomesFollow upKey resultsAdditional comments
Koray Karabulut et al. 2015Turkish Journal of Trauma and Emergency SurgeryTurkeyRetrospective Cohort StudyLevel IIITotal of 41 patientsGroup 1- Operative treatment (35)Group 2- Non-operative treatment (6)Primary end point-Failure of management (FM)FM rate wasGroup 1- 0%Group 2- 0%Single CentreRetrospective studySmall sample size
Negm et al. 2022World Journal of Emergency SurgeryEgyptProspective Randomised control trialLevel I bTotal of 100 patientsGroup 1- Operative treatment (50)Group 2-Non-operative treatment (50)Primary end point-Failure of management- Leak rate (LR)Leak rate (LR)Group 1–5%Group 2 - 2%Randomised prospective studySingle CentreSmall sample size
Feng Ciao et al. 2013Asian Journal of SurgeryChinaRetrospective Cohort StudyLevel IIITotal of 241 patientsGroup 1- Operative treatment (134)Group 2- Non-operative treatment (107)Primary end point-Failure of management (FM)- Abdominal abscess post managementAbdominal abscess post managementGroup 1–1.5%Group 2–3.7%Single CentreRetrospective studyLarge sample size
Jorge Vázquez et al. 2021Surgical EndoscopySwedenRetrospectiveRandomised control trialLevel I bTotal of 28 patientsGroup 1- Operative treatment (15)Group 2- Non-operative treatment (13)Primary end point-Failure of management (FM)- Post management complicationsPost management complicationsGroup 1–40.0%Group 2–53.8%Multicentre retrospective randomised studySmall sample size
Md Rahuman et al. 2003Ceylon Medical JournalBangladeshRetrospective Cohort StudyLevel IIITotal of 491 patientsGroup 1- Operative treatment (364)Group 2- Non-operative treatment for healthy patients presenting early (56)Group 3- Group 2- Non-operative treatmentFor elderly patients presenting late (71)Primary end point-Failure of management (FM)- Post management complicationsPost management complication rateGroup 1–35.9%Group 2 and 3 combined- 14.1%Retrospective studySingle centreLarge sample size
  17 in total

1.  Nonoperative management for perforated peptic ulcer: who can benefit?

Authors:  Feng Cao; Jia Li; Ang Li; Yu Fang; Ya-Jun Wang; Fei Li
Journal:  Asian J Surg       Date:  2014-01-03       Impact factor: 2.767

2.  Over-the-scope-clip applications for perforated peptic ulcer.

Authors:  Jing-Jing Wei; Xue-Ping Xie; Ting-Ting Lian; Zhi-Yong Yang; Yu-Feng Pan; Zhen-Lv Lin; Guang-Wei Zheng; Ze-Hao Zhuang
Journal:  Surg Endosc       Date:  2019-02-25       Impact factor: 4.584

Review 3.  Pathogenesis of Helicobacter pylori infection.

Authors:  Trinidad Parra Cid; Miryam Calvino Fernández; Selma Benito Martínez; Nicola L Jones
Journal:  Helicobacter       Date:  2013-09       Impact factor: 5.753

4.  Characteristics of serious complicated gastroduodenal ulcers in Japan.

Authors:  Shigenao Ishikawa; Tomoki Inaba; Motowo Mizuno; Yasuhiro Miyake; Hiroyuki Okada; Hisashi Ishikawa; Keisuke Hori; Masaki Wato; Kozo Kawai; Kazuhide Yamamoto
Journal:  Hepatogastroenterology       Date:  2012 Jan-Feb

Review 5.  Perforated duodenal ulcer: an alternative therapeutic plan.

Authors:  A J Donovan; T V Berne; J A Donovan
Journal:  Arch Surg       Date:  1998-11

6.  Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors.

Authors:  J Boey; S K Choi; A Poon; T T Alagaratnam
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

7.  A randomized trial of nonoperative treatment for perforated peptic ulcer.

Authors:  T J Crofts; K G Park; R J Steele; S S Chung; A K Li
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

8.  The Perforation-Operation time Interval; An Important Mortality Indicator in Peptic Ulcer Perforation.

Authors:  Sushama Surapaneni; Rajkumar S; Vijaya Bhaskar Reddy A
Journal:  J Clin Diagn Res       Date:  2013-05-01

Review 9.  Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.

Authors:  R J Hopkins; L S Girardi; E A Turney
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

10.  Stent treatment or surgical closure for perforated duodenal ulcers: a prospective randomized study.

Authors:  Jorge Alberto Arroyo Vázquez; Kaveh Khodakaram; Maria Bergström; Per-Ola Park
Journal:  Surg Endosc       Date:  2020-11-30       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.